Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Iohexol
Drug ID BADD_D01180
Description Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
Indications and Usage Iohexol ia used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures.
Marketing Status approved
ATC Code V08AB02
DrugBank ID DB01362
KEGG ID D01817
MeSH ID D007472
PubChem ID 3730
TTD Drug ID D02BLO
NDC Product Code 43228-100; 0407-1413; 71806-141; 0407-1414; 0407-1416; 0407-1415; 0407-1401; 0407-1411; 0407-1412; 65072-0801; 54702-501
UNII 4419T9MX03
Synonyms Iohexol | Iohexol 350 | Nycodenz | Compound 545 | Exypaque | Omnipaque
Chemical Information
Molecular Formula C19H26I3N3O9
CAS Registry Number 66108-95-0
SMILES CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Acute pulmonary oedema02.05.02.004; 22.01.03.0050.021340%Not Available
Acute respiratory failure22.02.06.001; 14.01.04.0040.014227%Not Available
Agitation19.06.02.001; 17.02.05.012--
Air embolism24.01.01.001; 12.02.05.0080.024897%Not Available
Altered state of consciousness17.02.04.001; 19.07.01.0030.024897%Not Available
Amaurosis06.02.10.0010.010670%Not Available
Amblyopia06.02.01.001--Not Available
Amnesia19.20.01.001; 17.03.02.001--
Amylase increased13.05.01.009--
Anaphylactic reaction24.06.03.006; 10.01.07.0010.428226%
Anaphylactic shock10.01.07.002; 24.06.02.0040.234742%Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.0030.064020%Not Available
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.0090.207000%Not Available
Anuria20.01.03.0020.007113%Not Available
Anxiety19.06.02.002--
Aortic aneurysm rupture24.02.03.0030.007113%Not Available
Aphasia19.21.01.001; 17.02.03.0010.053350%
Aphonia22.12.03.001; 19.19.01.002; 17.02.08.0090.014227%
Apnoea22.02.01.0010.029876%
Areflexia17.02.01.001--Not Available
Arrhythmia02.03.02.001--Not Available
Arterial spasm24.04.02.011--Not Available
Arterial thrombosis24.01.01.002--Not Available
Arteriospasm coronary12.02.01.031; 24.04.04.005; 02.02.02.0050.010670%Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Asphyxia22.02.02.001; 12.01.08.0110.014227%Not Available
Aspiration22.02.07.0070.021340%
Asterixis17.01.06.001; 09.01.03.004--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 13 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene